Search by Drug Name or NDC

    NDC 00225-0810-47 Neo-Synephrine Maximum 1 g/100mL Details

    Neo-Synephrine Maximum 1 g/100mL

    Neo-Synephrine Maximum is a NASAL SPRAY in the HUMAN OTC DRUG category. It is labeled and distributed by BF ASCHER AND CO INC. The primary component is PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00225-0810
    Product ID 0225-0810_0a49488a-841e-7937-e063-6294a90aeac8
    Associated GPIs 42102050102015
    GCN Sequence Number 008062
    GCN Sequence Number Description phenylephrine HCl SPRAY 1 % NASAL
    HIC3 Q7D
    HIC3 Description NOSE PREPARATIONS, VASOCONSTRICTORS(OTC)
    GCN 34124
    HICL Sequence Number 002087
    HICL Sequence Number Description PHENYLEPHRINE HCL
    Brand/Generic Generic
    Proprietary Name Neo-Synephrine Maximum
    Proprietary Name Suffix n/a
    Non-Proprietary Name PHENYLEPHRINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form SPRAY
    Route NASAL
    Active Ingredient Strength 1
    Active Ingredient Units g/100mL
    Substance Name PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name BF ASCHER AND CO INC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 00225-0810-47 (00225081047)

    NDC Package Code 0225-0810-47
    Billing NDC 00225081047
    Package 15 mL in 1 BOTTLE, SPRAY (0225-0810-47)
    Marketing Start Date 2020-07-01
    NDC Exclude Flag N
    Pricing Information N/A